16 June 2025 · 1 min read
Full Circle: Anne Wojcicki buys back 23andMe for $305M - now what?
Anne Wojcicki's company TTAM has outbid Regeneron with a $305M offer to buy back 23andMe's assets — and I'm intrigued about where this goes next.
Author
Last updated
6 May 2026
Full Circle: Anne Wojcicki buys back 23andMe for $305M - now what?
I previously posted about Regeneron winning the bid for the remaining assets of 23andMe. Now, in a thrilling twist, a company called TTAM ("23 and Me"'s initials), led by none other than 23andMe founder Anne Wojcicki, has outbid the biotech giant with a $305M offer.
I was already puzzled about Regeneron's potential plans for the genetic data assets, but this new development truly intrigues me. What do you think? Where do you see TTAM heading next?